Page last updated: 2024-10-22

alendronate and Muscle Weakness

alendronate has been researched along with Muscle Weakness in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaufman, JM1
Johnell, O1
Abadie, E1
Adami, S1
Audran, M1
Avouac, B1
Sedrine, WB1
Calvo, G1
Devogelaer, JP1
Fuchs, V1
Kreutz, G1
Nilsson, P1
Pols, H1
Ringe, J1
Van Haelst, L1
Reginster, JY1

Reviews

1 review available for alendronate and Muscle Weakness

ArticleYear
Background for studies on the treatment of male osteoporosis: state of the art.
    Annals of the rheumatic diseases, 2000, Volume: 59, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Alendronate; Body Height; Body Weight; Bone Density; Fractures

2000